EP1781688 - Bibliographic data

COMPOUNDS FOR PROTEASOME ENZYME INHIBITION

Last update	07/06/2025
Legal status	Brevet délivré
Origin	Euro-PCT

(73) Holder	ONYX THERAPEUTICS, INC. c/o Onyx Pharmaceuticals, Inc. 2100 Powell Street Emeryville, CA 94608 États-Unis d'Amérique
(72) Inventors	SMYTH, Mark, S. 700 East 19th Avenue, Apt 211 San Mateo, CA 94403 États-Unis d'Amérique LAIDIG, Guy, J. 329 Waverley Street Menlo Park, CA 94025 États-Unis d'Amérique
(74) Agent	Mail recipient CARLISLE, JULIE ET AL Mewburn Ellis LLP 33 Gutter Lane London EC2V 8AS Royaume-Uni

(21) Request number	EP05784484.7
(22) Request date	08/08/2005

(11) Publication number	EP1781688
Publication date	19/01/2011

(54) Title of the invention	COMPOUNDS FOR PROTEASOME ENZYME INHIBITION
(51) International classification	C07K 5/087, A61K 38/07, A61K 38/06, C07K 5/103, C07K 5/02
International classification (before reform)	None

Claimed priority	(31) Number: 599401 P (32) Date: 06/08/2004 (33) Country: US (31) Number: 610001 P (32) Date: 14/09/2004 (33) Country: US (31) Number: 106879 (32) Date: 14/04/2005 (33) Country: US
Initial application	None
Divisional application	EP10012498.1 /EP2266999EP10012497.3 /EP2270026 None

Expected annuity	None
Last annuity	Annuity: 20 - Payment date 29/07/2024

Publication	BREVETS D'INVENTION DESIGNANT MC DELIVRES PAR l'OEB - bulletin 2011/1, of 31/03/2011
History	Publication de la délivrance du brevet européen - Legal date 19/01/2011 Constitution de mandataire pour un dossier - Legal date 14/07/2011 Modification du mandataire OEB du brevet européen - Legal date 02/11/2011